Abstract: Type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD) are both major chronic diseases in China. In clinical practice, cardiac metabolic risk factors, such as overweight, obesity, abnormal glucose metabolism, and dyslipidemia, often cluster together. ASCVD is the major cause of death due to metabolic diseases including T2DM, and comprehensive intervention can effectively improve the prognosis of cardiovascular and metabolic disease (CMD). Therefore, primary medical institutions should pay attention to CMD and implement early diagnosis, hierarchical diagnosis and treatment, and whole-course management. With reference to the latest authoritative guide and primary diagnosis and treatment practice, Working Committee of Primary Health Talents of China National Health Association and Shenzhen Clinical Medical Research Center for Metabolic Diseases organized an expert group to formulate Expert consensus on primary comprehensive prevention and control of cardiovascular and metabolic disease, which centers on patients and establishes general practitioners as the main body of prevention and control, with technical support provided by specialists. This expert consensus aims to standardize the comprehensive diagnosis and treatment of CMD in primary medical institutions, including risk assessment, early diagnosis, metabolic control, graded referral, and whole-course management, so as to advance the frontier of CMD prevention and control and reduce the incidence of ASCVD events.

Key words: Cardiovascular and metabolic disease, Type 2 diabetes, Atherosclerotic cardiovascular disease, Comprehensive prevention and control, Primary medical institution